In part 3 of this Exclusive Interview, Dace Trence talks with Diabetes in Control during the AACE 2018 convention in Boston about the usefulness of CGMs for people who are not on insulin therapy.

In part 4 of this Exclusive Interview, Dace Trence talks with Diabetes in Control during the AACE 2018 convention in Boston about the latest treatments and possible treatments coming down the pike in diabetes care.

In part 5, the conclusion of this Exclusive Interview, Dace Trence talks with Diabetes in Control during the AACE 2018 convention in Boston about diabetes and cardiovascular combo therapy, and how new medications and precision medicine are changing diabetes care.

And increase in midlife death rates across racial and ethnic groups in the United States

Early in my diabetes career, our publisher and my mentor, Steve Freed, had me live like I had diabetes for 2 weeks. I had to check my glucose before every meal, and count my carbs and calculate an insulin dose each time I ate. Although I didn’t have diabetes, he …

An SGLT-2 inhibitor reduces liver fat and ALT levels in people who have type 2 diabetes.

Elevated eGR fund to possibly lead to renal damage.

Even as 2nd-line drugs, sulfonylureas shown to be cardiotoxic with high rate of low blood glucose

Patients who have normoglycemia still at risk for glucose spikes and diabetes.

Study investigates preservation or improvement of B-cell function using metformin with or without short-term insulin.